1
|
Lin F, Zheng B. Cryopreservation of human spermatozoa by freezing testicular seminiferous tubule with novel cryopiece. Andrologia 2021; 54:e14356. [PMID: 34957581 PMCID: PMC9285044 DOI: 10.1111/and.14356] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2021] [Revised: 11/20/2021] [Accepted: 12/10/2021] [Indexed: 12/02/2022] Open
Abstract
This study was carried out to evaluate the effectiveness of cryopreservation of human spermatozoa by freezing testicular seminiferous tubule with a new cryocarrier named ‘novel cryopiece’. Testicular tissue (TT) was collected from patients who underwent diagnostic testicular biopsy. Overall, 35 TT samples were obtained. Each TT sample was equally divided into four groups named (e.g. G1, G2, G3 and Gc). G1 was frozen as testicular seminiferous tubule using novel cryopiece, G2 was frozen as testicular cell suspensions using novel cryopiece, G3 was frozen as testicular cell suspensions using 0.25 ml straw, and Gc was not frozen. The samples in G1 and G2 experimental groups were cryopreserved in five separate aliquots and stored in the same cryovial. The freeze–thaw sperm DNA fragmentation index (DFI) of G2 was lower than that of G3 (20.27 ± 5.40 vs 23.55 ± 6.02; p = 0.004). After thawing, spermatozoa could be found in all 35 testicular seminiferous tubule specimens in G1; however, it could not be found in 2 of 35 (5.7%) and 1 of 35 (2.9%) testicular cell suspensions samples in G2 and G3 respectively. This study indicates that novel cryopiece presented for the cryopreservation of testicular seminiferous tubules and testicular cell suspension is simple and effective.
Collapse
Affiliation(s)
- Feng Lin
- Center of Reproductive Medicine, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, China
| | - Beihong Zheng
- Center of Reproductive Medicine, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, China
| |
Collapse
|
2
|
Maleki B, Khalili MA, Gholizadeh L, Mangoli E, Agha-Rahimi A. Single sperm vitrification with permeable cryoprotectant-free medium is more effective in patients with severe oligozoospermia and azoospermia. Cryobiology 2021; 104:15-22. [PMID: 34822804 DOI: 10.1016/j.cryobiol.2021.11.176] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Revised: 09/27/2021] [Accepted: 11/21/2021] [Indexed: 12/24/2022]
Abstract
Testicular sperm extraction (TESE) is an invasive surgery for achieving the spermatozoa in cases with azoospermia. In these patients, the number of retrieved spermatozoa is limited and the optimal cryo-storage is very critical for their fertility preservation. Therefore, single sperm vitrification has been introduced for preservation of low number of spermatozoa. The goal was to assess the efficacy of sperm freezing medium (SFM) and sucrose medium as cryoprotectants for single sperm vitrification in cases with severe oligozoospermia and azoospermia. A total of 20 ejaculates from severe oligozoospermia and 20 testicular samples from azoospermia were processed. Twenty-five sperm cells were collected using ICSI injection pipette and transferred to a cryoprotectant droplet placed on the Cryotech, then vitrified by plunging in liquid nitrogen. Sperm motility, viability, fine-morphology, mitochondrial activity and DNA fragmentation index (DFI) were assessed before and after vitrification. Sperm motility, viability and the percentage of cells with mitochondrial activity were significantly decreased after vitrification in both severe oligozoospermic and testicular samples in either cryoprotectants. However, the rates of post-warm sperm motility and the cells with mitochondrial activity increased significantly in sucrose medium in both severe oligozoospermic and testicular samples compared to SFM. In testicular samples, the DFI of spermatozoa vitrified in SFM was significantly higher than those vitrified with sucrose medium. Sperm motility, viability, mitochondrial activity, and DNA integrity were better preserved in sucrose medium than SFM after single cell vitrification. The presented method may be a useful candidate for successful freezing of individual sperm cells in clinical setting.
Collapse
Affiliation(s)
- Behnam Maleki
- Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
| | - Mohammad Ali Khalili
- Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
| | - Lida Gholizadeh
- Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
| | - Esmat Mangoli
- Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
| | - Azam Agha-Rahimi
- Abortion Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
| |
Collapse
|
3
|
Abstract
BACKGROUND Patients with severe oligospermia and nonobstructive azoospermia have very limited numbers of viable sperm in their epididymal and testicular samples. Thus, cryopreservation of their sperm is performed to avoid repeated sperm retrievals and to preserve their sperm from any side effects of any treatment regimens. MAIN BODY The development of intracytoplasmic sperm injection technology has extended the therapeutic capacity of assisted reproductive technology for men with azoospermia via the surgical or percutaneous isolation of sperm from the testis/epididymis. The conventional cryopreservation techniques are inadequate for preserving individually selected sperm. The technique for freezing single sperm was first developed in 1997 and has been explored from the perspective of frozen carriers, freezing programs, and cryoprotectant formulations. Among these methods, advances in frozen carriers have directly improved single-sperm freezing technology. In this review, we evaluate the different technologies for the cryopreservation of single sperm by discussing the advantages and disadvantages of different freezing methods, their clinical applications, and the outcomes for a range of frozen carriers. CONCLUSION Our review article describes the latest and current technologies implemented for the cryopreservation of single sperm that could potentially benefit patients with severe oligospermia and who rarely have any sperm in their ejaculate. This review provides a platform to understand the process and pitfalls of single-sperm cryopreservation to ensure further improvements in the cryopreservation technology in future studies.
Collapse
Affiliation(s)
- Shasha Liu
- grid.461863.e0000 0004 1757 9397Human Sperm Bank, West China Second University Hospital, Sichuan University, Chengdu, 610041 China
- grid.419897.a0000 0004 0369 313XKey Laboratory of Birth Defects and Related Disease of Women and Children (Sichuan University), Ministry of Education, Chengdu, 610041 China
| | - Fuping Li
- grid.461863.e0000 0004 1757 9397Human Sperm Bank, West China Second University Hospital, Sichuan University, Chengdu, 610041 China
- grid.419897.a0000 0004 0369 313XKey Laboratory of Birth Defects and Related Disease of Women and Children (Sichuan University), Ministry of Education, Chengdu, 610041 China
| |
Collapse
|
4
|
Evaluation and improvement of the novel method for vitrification of a few human sperms. Eur J Obstet Gynecol Reprod Biol 2019; 240:74-79. [PMID: 31234060 DOI: 10.1016/j.ejogrb.2019.06.021] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2018] [Revised: 06/12/2019] [Accepted: 06/16/2019] [Indexed: 01/12/2023]
Abstract
RESEARCH QUESTION The purposes of this study are to evaluate the performance of the novel SpermVD device on vitrification of a few human sperms, and determine whether PICSI dish and density gradient centrifugation can improve the quality of sperm after thawing. DESIGN AND METHODS In order to determine the suitable preparation methods, both washed sperm and neat sperm were selected in ICSI dish and PICSI dish, and frozen with the novel SpermVD device. The selected sperms were transferred to freezing droplets with 1 μl droplet of a 50/50 v/v mixture of QA Sperm Freezing Medium and QA Medium w/Hepes on the SpermVD wells. And the device was exposed to vapor of liquid nitrogen for 5 min and then placed into LN2 immediately. The sperms were thawed in a 37℃ oil filled dish which contained QA Medium w/Hepes droplets and they were searched and revaluated immediately. The frozen effects of sperm were evaluated by progressive motility, motility, viability and recovery rates of freezing-thawing sperm. RESULTS After freezing-thawing, the overall sperm recovery rate was 94.2% with 70% viability, 20.7% progressive motility, and 36.2% motility. The progressive motility, motility, viability and recovery rates of washed sperm were lower than that of the neat sperm, with a significant difference (P < 0.01) at both viability and motility rates. In addition, the viability rate was significantly higher in PICSI dish group than that of ICSI dish group (P < 0.01) and the motility, recovery and progressive motility rates were not significantly different between the two groups (P > 0.05). CONCLUSIONS The spermVD device was one of the effective platforms for freezing a few human sperms and using PICSI dish to select mature neat sperms could improve the quality of sperm after thawing. Density gradient centrifugation might be not required or suitable sperm preparation methods before freezing.
Collapse
|
5
|
Hezavehei M, Sharafi M, Kouchesfahani HM, Henkel R, Agarwal A, Esmaeili V, Shahverdi A. Sperm cryopreservation: A review on current molecular cryobiology and advanced approaches. Reprod Biomed Online 2018; 37:327-339. [PMID: 30143329 DOI: 10.1016/j.rbmo.2018.05.012] [Citation(s) in RCA: 195] [Impact Index Per Article: 32.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2017] [Revised: 05/19/2018] [Accepted: 05/22/2018] [Indexed: 11/19/2022]
Abstract
The cryopreservation of spermatozoa was introduced in the 1960s as a route to fertility preservation. Despite the extensive progress that has been made in this field, the biological and biochemical mechanisms involved in cryopreservation have not been thoroughly elucidated to date. Various factors during the freezing process, including sudden temperature changes, ice formation and osmotic stress, have been proposed as reasons for poor sperm quality post-thaw. Little is known regarding the new aspects of sperm cryobiology, such as epigenetic and proteomic modulation of sperm and trans-generational effects of sperm freezing. This article reviews recent reports on molecular and cellular modifications of spermatozoa during cryopreservation in order to collate the existing understanding in this field. The aim is to discuss current freezing techniques and novel strategies that have been developed for sperm protection against cryo-damage, as well as evaluating the probable effects of sperm freezing on offspring health.
Collapse
Affiliation(s)
- Maryam Hezavehei
- Department of EmbryologyReproductive Biomedicine Research CentreRoyan Institute for Reproductive BiomedicineACECRTehranIran; Department of Animal BiologyFaculty of Biological SciencesKharazmi UniversityTehranIran
| | - Mohsen Sharafi
- Department of Poultry ScienceFaculty of AgricultureTarbiat Modares UniversityTehranIran.
| | | | - Ralf Henkel
- American Centre for Reproductive MedicineCleveland ClinicClevelandUSA
| | - Ashok Agarwal
- Department of Medical BioscienceUniversity of the Western CapeBellvilleSouth Africa
| | - Vahid Esmaeili
- Department of EmbryologyReproductive Biomedicine Research CentreRoyan Institute for Reproductive BiomedicineACECRTehranIran
| | - Abdolhossein Shahverdi
- Department of EmbryologyReproductive Biomedicine Research CentreRoyan Institute for Reproductive BiomedicineACECRTehranIran.
| |
Collapse
|
6
|
Kathrins M, Abhyankar N, Shoshany O, Liebermann J, Uhler M, Prins G, Niederberger C. Post-thaw recovery of rare or very low concentrations of cryopreserved human sperm. Fertil Steril 2017; 107:1300-1304. [PMID: 28483505 DOI: 10.1016/j.fertnstert.2017.04.016] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2016] [Revised: 04/18/2017] [Accepted: 04/18/2017] [Indexed: 10/19/2022]
Abstract
OBJECTIVE To analyze cases in which no sperm could be identified after thawing among cryopreserved samples of rare or very low concentrations of sperm. DESIGN Retrospective, single-institution, cross-sectional. SETTING Male infertility clinic. PATIENT(S) We identified couples that underwent intracytoplasmic sperm injection (ICSI) with the use of either ejaculated or testicular cryopreserved-thawed sperm. Inclusion criteria were men with <100,000 total ejaculated sperm or men with azoospermia due to spermatogenic dysfunction who underwent microsurgical testicular sperm extraction with similarly low pre-cryopreservation sperm counts. Pre-cryopreservation specimens were categorized as "rare sperm only" (Group 1) or <100,000 total sperm (group 2). "Rare sperm only" applied to cases in which only one to three sperm were identified in a search of >20 high-power fields. INTERVENTION(S) None. MAIN OUTCOME MEASURE(S) Cases in which no sperm were able to be found post-thaw (i.e., complete cellular loss) for use at the time of a programmed IVF cycle. RESULT(S) We analyzed 55 men (83 ICSI cycles). There were five ICSI cycles (6.0%) among five different couples in which no sperm could be identified post-thaw. Of these, four cases were from group 1 (8.5%) and one from group 2 (2.8%). Complete cellular loss occurred in 5.8% of testicular sperm samples and 7.1% of ejaculated sperm samples. There were no statistical associations between the ability to locate sperm post-thaw and the pre-cryopreservation parameters or sperm source. CONCLUSION(S) Failure to retrieve any sperm after thawing of rare or very low concentrations of cryopreserved sperm is an infrequent event and largely limited to those patients with rare quantities of sperm.
Collapse
Affiliation(s)
- Martin Kathrins
- Division of Urology, Brigham and Women's Hospital, Boston, Massachusetts.
| | - Nikita Abhyankar
- Department of Urology, University of Illinois, Chicago, Illinois
| | - Ohad Shoshany
- Department of Urology, University of Illinois, Chicago, Illinois
| | | | - Meike Uhler
- Fertility Centers of Illinois, Chicago, Illinois
| | - Gail Prins
- Department of Urology, University of Illinois, Chicago, Illinois
| | | |
Collapse
|
7
|
Stein A, Shufaro Y, Hadar S, Fisch B, Pinkas H. Successful use of the Cryolock device for cryopreservation of scarce human ejaculate and testicular spermatozoa. Andrology 2015; 3:220-4. [PMID: 25656321 DOI: 10.1111/andr.12007] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2014] [Revised: 10/30/2014] [Accepted: 12/11/2014] [Indexed: 11/28/2022]
Abstract
The existing methods for cryopreservation of very low count sperm samples are complex and sub-optimal for individual spermatozoa. Our purpose is to establish an effective simple method for cryoprotecting individual spermatozoa. Samples from patients with OTA were mixed with TYB or HEPES-buffered salt solution with glycerol + glucose and placed on a Cryolock that was plunged directly into liquid nitrogen or exposed to its vapors. Thawing was performed by direct immersion into a drop of warmed medium. The favorable method was tested on diluted samples (10-50 cells) and leftover TESE specimens from patients with azoospermia. Cryopreservation was considered successful if >30 spermatozoa, (>3 motile), or >5 spermatozoa (>1 motile) in diluted and TESE samples, were detected post-thawing. A significantly higher survival rate of seminal spermatozoa was obtained when using the Cryolock with TYB and freezing with liquid nitrogen vapor, compared to HEPES glycerol-glucose (95 vs. 35% respectively). Plunging the Cryolock into liquid nitrogen was detrimental. Cryolock combined with TYB cryoprotection and liquid nitrogen vapor freezing was highly effective for cryopreservation of individual spermatozoa in diluted and TESE samples. The Cryolock may serve for freezing very low-count sperm samples and individual spermatozoa. This method offers simplicity, efficacy, use of available materials, without requiring micromanipulation equipment or skills.
Collapse
Affiliation(s)
- A Stein
- Sperm Bank, Beilinson's Women's Hospital, Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | | | | | | | | |
Collapse
|
8
|
Sharma R, Kattoor AJ, Ghulmiyyah J, Agarwal A. Effect of sperm storage and selection techniques on sperm parameters. Syst Biol Reprod Med 2014; 61:1-12. [DOI: 10.3109/19396368.2014.976720] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
9
|
Human Sperm Cryopreservation: Update on Techniques, Effect on DNA Integrity, and Implications for ART. Adv Urol 2011; 2012:854837. [PMID: 22194740 PMCID: PMC3238352 DOI: 10.1155/2012/854837] [Citation(s) in RCA: 163] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2011] [Revised: 09/22/2011] [Accepted: 09/27/2011] [Indexed: 11/18/2022] Open
Abstract
Cryopreservation of human spermatozoa-introduced in the 1960's-has been recognized as an efficient procedure for management of male fertility before therapy for malignant diseases, vasectomy or surgical infertility treatments, to store donor and partner spermatozoa before assisted reproduction treatments and to ensure the recovery of a small number of spermatozoa in severe male factor infertility. Despite the usefulness of it, cryopreservation may lead to deleterious changes of sperm structure and function: while the effects of cryopreservation on cells are well documented, to date there is no agreement in the literature on whether or not cryopreservation affects sperm chromatin integrity or on the use of a unique and functional protocol for the freezing-thawing procedure. Therefore, sperm cryopreservation is an important component of fertility management and much of its successful application seems to affect the reproductive outcome of assisted reproduction technologies (ART): appropriate use of cryoprotectants before and sperm selection technologies after cryopreservation seem to have the greatest impact on preventing DNA fragmentation, thus improving sperm cryosurvival rates.
Collapse
|
10
|
Peng QP, Cao SF, Lyu QF, Xue SG, Jin W, Liu XY, Zhang WJ, Nielsen HI, Kuang YP. A novel method for cryopreservation of individual human spermatozoa. In Vitro Cell Dev Biol Anim 2011; 47:565-72. [PMID: 21638160 DOI: 10.1007/s11626-011-9428-1] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2011] [Accepted: 05/15/2011] [Indexed: 11/27/2022]
Abstract
The purpose of this study is to develop a novel method for the cryopreservation and efficient post-thaw recovery of individual or small numbers of human spermatozoa. Spermatozoa equilibrated in cryoprotectant buffer were injected with an intracytoplasmic sperm injection (ICSI) needle into a droplet of cryoprotectant on a homemade cryoleaf. The droplet was of cryoprotectant and seminal plasma at a ratio of 1:1. The sperm-loaded cryoleaf was slowly lowered over and stored in liquid nitrogen. Spermatozoa were thawed in a 37°C oil bath without dilution and centrifugation. To test the fertilizing ability of these spermatozoa, the recovered spermatozoa were injected by ICSI into 1-d-old or in vitro-matured human oocytes. Fresh spermatozoa from the same semen samples served as controls. The trials were performed in two separate experiments. In the first set of experiments, 92 spermatozoa were thawed and carefully investigated. The spermatozoa from percutaneous epididymal sperm aspiration had a motility recovery of 92.9% (13/14); ejaculated spermatozoa had a motility recovery of 61.5% (48/78), and only 1.3% (1/78) was lost. Together in the first and second set of experiments, the fertilization rates for the fresh and frozen-thawed spermatozoa were 67.6% (25/37) and 60.6% (40/66), respectively (P = 0.052). The mean embryo cleavage rates in the fresh and frozen-thawed groups were 88% (22/25) and 85% (34/40), respectively (P = 0.990). This cryopreservation method for individual or small numbers of human spermatozoa was efficient and simple. These findings make this method a promising technique for the clinical application of ejaculated sperm from oligozoospermic patients.
Collapse
Affiliation(s)
- Qiu-Ping Peng
- Department of Assisted Reproduction, Shanghai 9th People's Hospital, School of Medicine, Shanghai Jiao Tong University, 639 ZhiZaoJu Road, 200011, Shanghai, China.
| | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Evaluation of human sperm function after being cryopreserved within the zona pellucida. Fertil Steril 2009; 92:1002-1008. [DOI: 10.1016/j.fertnstert.2008.07.1737] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2008] [Revised: 07/05/2008] [Accepted: 07/15/2008] [Indexed: 11/20/2022]
|
12
|
AbdelHafez F, Bedaiwy M, El-Nashar SA, Sabanegh E, Desai N. Techniques for cryopreservation of individual or small numbers of human spermatozoa: a systematic review. Hum Reprod Update 2008; 15:153-64. [PMID: 19109313 DOI: 10.1093/humupd/dmn061] [Citation(s) in RCA: 69] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Despite interest in cryopreservation of individual or small number of human spermatozoa, to date, little data is available as regards its effectiveness. We systematically reviewed the outcome after cryopreservation of individual or small numbers of human spermatozoa in patients with severe male factor of infertility. METHODS We searched the MEDLINE, EMBASE, Cochrane Systematic Reviews, CENTRAL, Web of Science, Scopus databases for relevant studies up to June of 2008. The search used terms referring to cryopreservation of small amount of sperm. Included studies were limited to human studies with no language restrictions. RESULTS We identified 30 reports including 9 carriers used for cryopreservation of small quantities/numbers of human spermatozoa (7 non-biological and 2 biological carriers). A wide variety of cryopreservation vehicles were reported. The recovery rate of spermatozoa cryopreserved in a known small number varied widely from 59 to 100%. Fertilization rates were in the range of 18-67%. Frozen-thawed spermatozoa, using this method, were subsequently used for intracytoplasmic sperm injection in only five studies, with few pregnancies reported so far. To date, there remains no consensus as to the ideal carrier for cryopreservation of small number of spermatozoa for clinical purposes. CONCLUSIONS Cryopreservation of individual or small numbers of human spermatozoa may replace the need for repeated surgical sperm retrieval. A controlled multicenter trial with sufficient follow-up would provide valid evidence of the potential benefit of this approach.
Collapse
Affiliation(s)
- Faten AbdelHafez
- Department of Obstetrics and Gynecology, Cleveland Clinic Fertility Centre, Cleveland Clinic Foundation, OH 44122, USA
| | | | | | | | | |
Collapse
|
13
|
Sereni E, Bonu MA, Fava L, Sciajno R, Serrao L, Preti S, Distratis V, Borini A. Freezing spermatozoa obtained by testicular fine needle aspiration: a new technique. Reprod Biomed Online 2008; 16:89-95. [DOI: 10.1016/s1472-6483(10)60560-3] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
14
|
Hassa H, Gurer F, Yildirim A, Can C, Sahinturk V, Tekin B. A New Protection Solution for Freezing Small Numbers of Sperm Inside Empty Zona Pellucida: Osmangazi-Turk Solution. ACTA ACUST UNITED AC 2006. [DOI: 10.1089/cpt.2006.4.199] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Hikmet Hassa
- Department of Obstetrics and Gynecology, Eskisehir Osmangazi University, Eskisehir, Turkey
| | - Firdevs Gurer
- Department of Histology and Embryology, Eskisehir Osmangazi University, Eskisehir, Turkey
| | - Attila Yildirim
- Department of Obstetrics and Gynecology, Eskisehir Osmangazi University, Eskisehir, Turkey
| | - Cavit Can
- Urology Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
| | - Varol Sahinturk
- Department of Histology and Embryology, Eskisehir Osmangazi University, Eskisehir, Turkey
| | - Basar Tekin
- Department of Obstetrics and Gynecology, Eskisehir Osmangazi University, Eskisehir, Turkey
| |
Collapse
|
15
|
Woods EJ, Benson JD, Agca Y, Critser JK. Fundamental cryobiology of reproductive cells and tissues. Cryobiology 2004; 48:146-56. [PMID: 15094091 DOI: 10.1016/j.cryobiol.2004.03.002] [Citation(s) in RCA: 210] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2003] [Accepted: 03/12/2004] [Indexed: 11/30/2022]
Abstract
During the last half of the 20th century there have been considerable advancements in mammalian reproductive technologies, including in vitro production of pre-implantation embryos and embryo sexing, and even cloning in some species. However, in most cases, management of non-cryopreserved reproductive cells (i.e., spermatozoa or oocytes) and tissues (i.e., testicular tissue or ovarian tissue) is problematic due to difficulties in donor-recipient synchronization and the potential for transmission of infectious pathogens, which cumulatively limits widespread application of these techniques. Therefore, there is an urgent need for the development of optimum cryopreservation methods for reproductive cells and tissues from many species. Today frozen-thawed spermatozoa and embryos have become an integral component of animal agriculture, laboratory animal genome banking, and human sperm banking and infertility programs. However, although widely implemented, the protocols currently used to cryopreserve bull sperm, for example, are still suboptimal, and cannot readily be extrapolated to other species' sperm. Similarly, embryo-freezing protocols successfully used for mouse and cattle have yielded little success when applied to some other species' embryos, or to a related cell type, oocytes. To date, with the exception of mouse oocytes, almost all mammalian species' oocytes studied have proven very difficult to successfully cryopreserve. Currently, there is a growing interest to understand the underlying cryobiological fundamentals responsible for these low survival rates in an effort to develop better cryopreservation methods for oocytes. Additionally, there is growing interest in developing technologies for the optimal isolation and cryopreservation of the earliest stage of male (spermatogonia, spermatids) and female (primordial follicle) germ cells, with subsequent maturation to the desired stage in vitro. Female gamete maturation, fertilization, and embryo development entirely under in vitro conditions from primordial follicles has been achieved in mice, however techniques for this and other species are still very early in their development. Furthermore, with the recent advances made in intracytoplasmic sperm injection (ICSI), and gamete isolation and maturation, close attention has been given to cryopreservation of gametes in the form of gonadal tissue (i.e., testicular tissue and ovarian tissue) containing various developmental stages of male (spermatogonia, spermatids, and spermatozoa) and female (primordial, secondary) germ lines.
Collapse
Affiliation(s)
- Erik J Woods
- General BioTechnology, LLC, Harlan Biotechnology Center, 1102 Stadium Drive, Indianapolis, IN 46202, USA
| | | | | | | |
Collapse
|
16
|
Longhi A, Macchiagodena M, Vitali G, Bacci G. Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma. J Pediatr Hematol Oncol 2003; 25:292-6. [PMID: 12679642 DOI: 10.1097/00043426-200304000-00005] [Citation(s) in RCA: 74] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
PURPOSE To evaluate fertility in male patients with osteosarcoma after chemotherapy including high doses of alkylating agents. PATIENTS AND METHODS Postchemotherapy fertility was evaluated in 96 male patients who received chemotherapy at the authors' institution from 1976 to 1996 for localized bone osteosarcoma of the extremities. Four drugs were administrated (doxorubicin, cisplatin, methotrexate, ifosfamide) at different doses according to six different protocols. Eleven patients were prepubertal and 85 were postpubertal at the time of chemotherapy. The median age of these patients at the time of chemotherapy was 17 years (range 10-42), the median age at the time of the interview was 27 years (range 19-53), and the median follow-up from the end of chemotherapy was 9 years (range 4-17). RESULTS Of the 96 patients, 26 underwent sperm analysis and 20 showed oligo- or azoospermia. Patients who received high-dose ifosfamide showed a higher incidence of azoospermia. Six patients were normospermic and received no ifosfamide or lower doses of ifosfamide. Eight patients fathered a total of 12 children. No birth defects or congenital anomalies were observed in their offspring. CONCLUSIONS The rate of sterility was related to ifosfamide dosage. It appears that pubertal maturation is not affected by chemotherapy. No congenital malformations were seen in the children of the few patients who fathered children.
Collapse
Affiliation(s)
- Alessandra Longhi
- Department of Musculoskeletal Oncology, Rizzoli Orthopaedic Institute, Bologna, Italy.
| | | | | | | |
Collapse
|